Company: TBPH
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0001558370-25-002447
Chunk: 26

Company: Theravance Biopharma, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 5
Chunk 26
---
ITEM 5.  MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our ordinary shares have traded on The Nasdaq Global Market under the symbol “TBPH” since June 3, 2014. As of February 26, 2025, there were 39 shareholders of record of our ordinary shares. As many of our ordinary shares are held by brokers and other institutions on behalf of shareholders, we are unable to estimate the total number of underlying shareholders represented by these shareholders of record.

​

Dividend Policy

We have never declared or paid cash dividends on our ordinary shares. We currently intend to retain future earnings to finance our ongoing operations. We have committed to return excess capital to shareholders. Our board of directors will determine the form of any future return of excess capital to shareholders.

​

Equity Compensation Plans

The following table provides certain information with respect to all of our equity compensation plans as of December 31, 2024:

​​​​​​​​​    ​    ​​    Number of Securities​​​​​​​Remaining Available​​Number of Securities​​​​for Future Issuance​​to be Issued Upon​Weighted-Average​Under Equity​​Exercise of​Exercise Price of​Compensation Plans​​Outstanding Options,​Outstanding Options,​(excluding securitiesPlan Category    Warrants and Rights (a)    Warrants and Rights    reflected in column (a))Options  1,829,168​$ 15.53  4,426,322Restricted share units  3,955,487​ n/a n/aEmployee share purchase plan (suspended as of December 31, 2024) n/a​ n/a  3,447,685Equity compensation plans approved by security holders  5,784,655​$ 15.53  7,874,007​​​​​​​​Options  67,740​$ 15.52  —Equity compensation plans not approved by security holders  67,740​$ 15.52  —Total  5,852,395​$ 15.53  7,874,007

​

During 2024, we had three equity compensation plans — our